Key points are not available for this paper at this time.
Over 30 years, the survival of patients with de novo M1 disease modestly and unevenly increased among cancers. Metastatic cancer still remains a very lethal disease. Next to better treatment options, we call for better preventive measures and early detection to reduce the incidence of metastatic disease.
Building similarity graph...
Analyzing shared references across papers
Loading...
Marianne Luyendijk
Institute of Technology Assessment
Otto Visser
Media Working Group
Hedwig M. Blommestein
Erasmus University Rotterdam
JNCI Journal of the National Cancer Institute
Radboud University Nijmegen
University of Groningen
Erasmus University Rotterdam
Building similarity graph...
Analyzing shared references across papers
Loading...
Luyendijk et al. (Wed,) studied this question.
synapsesocial.com/papers/69dd60affb7610310c102aed — DOI: https://doi.org/10.1093/jnci/djad020